DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,908,724 | +5.8% | 11,724 | +2.3% | 0.02% | +10.0% |
| Q2 2023 | $2,749,440 | -4.6% | 11,456 | +0.2% | 0.02% | -9.1% |
| Q1 2023 | $2,881,069 | +95142.0% | 11,431 | +0.3% | 0.02% | -4.3% |
| Q4 2022 | $3,025 | -99.9% | 11,396 | -0.9% | 0.02% | -8.0% |
| Q3 2022 | $2,969,000 | -0.3% | 11,496 | -2.1% | 0.02% | +8.7% |
| Q2 2022 | $2,978,000 | -15.5% | 11,746 | -2.3% | 0.02% | +4.5% |
| Q1 2022 | $3,526,000 | -10.8% | 12,021 | 0.0% | 0.02% | -8.3% |
| Q4 2021 | $3,955,000 | +4.8% | 12,021 | -3.1% | 0.02% | 0.0% |
| Q3 2021 | $3,775,000 | +6.3% | 12,401 | -6.3% | 0.02% | -22.6% |
| Q2 2021 | $3,552,000 | +17.5% | 13,236 | -1.5% | 0.03% | +6.9% |
| Q1 2021 | $3,024,000 | +1.3% | 13,436 | 0.0% | 0.03% | -9.4% |
| Q4 2020 | $2,985,000 | +7.4% | 13,436 | +4.1% | 0.03% | +6.7% |
| Q3 2020 | $2,780,000 | +15.7% | 12,911 | -5.0% | 0.03% | +11.1% |
| Q2 2020 | $2,403,000 | +28.5% | 13,590 | +0.6% | 0.03% | +8.0% |
| Q1 2020 | $1,870,000 | -10.1% | 13,510 | -0.4% | 0.02% | +13.6% |
| Q4 2019 | $2,081,000 | -7.4% | 13,560 | -12.9% | 0.02% | -12.0% |
| Q3 2019 | $2,248,000 | -2.3% | 15,564 | -3.3% | 0.02% | -3.8% |
| Q2 2019 | $2,300,000 | +7.1% | 16,094 | -1.0% | 0.03% | +8.3% |
| Q1 2019 | $2,147,000 | -39.9% | 16,264 | -53.1% | 0.02% | -45.5% |
| Q4 2018 | $3,575,000 | -4.8% | 34,670 | +0.3% | 0.04% | +18.9% |
| Q3 2018 | $3,756,000 | +6.8% | 34,570 | -3.0% | 0.04% | +2.8% |
| Q2 2018 | $3,517,000 | -81.7% | 35,645 | -81.8% | 0.04% | -81.9% |
| Q1 2018 | $19,222,000 | -3.5% | 196,320 | -8.5% | 0.20% | +1.0% |
| Q4 2017 | $19,921,000 | +426.6% | 214,616 | +386.7% | 0.20% | +233.9% |
| Q3 2017 | $3,783,000 | +2.3% | 44,100 | +0.7% | 0.06% | +1.7% |
| Q2 2017 | $3,697,000 | -2.7% | 43,810 | -1.3% | 0.06% | -4.9% |
| Q1 2017 | $3,798,000 | +8.3% | 44,400 | -1.5% | 0.06% | +3.4% |
| Q4 2016 | $3,508,000 | -2.0% | 45,065 | -1.3% | 0.06% | -7.8% |
| Q3 2016 | $3,579,000 | -19.2% | 45,660 | +4.1% | 0.06% | -22.9% |
| Q2 2016 | $4,432,000 | +4.9% | 43,880 | -1.5% | 0.08% | +1.2% |
| Q1 2016 | $4,225,000 | +0.2% | 44,540 | -1.9% | 0.08% | -3.5% |
| Q4 2015 | $4,217,000 | +7.5% | 45,400 | -1.4% | 0.08% | +4.9% |
| Q3 2015 | $3,922,000 | +0.1% | 46,025 | +0.5% | 0.08% | +11.0% |
| Q2 2015 | $3,918,000 | +2.6% | 45,775 | +1.8% | 0.07% | -3.9% |
| Q1 2015 | $3,818,000 | -0.9% | 44,975 | +0.0% | 0.08% | -2.6% |
| Q4 2014 | $3,854,000 | -18.8% | 44,966 | -28.0% | 0.08% | -21.2% |
| Q3 2014 | $4,746,000 | -4.3% | 62,471 | -0.8% | 0.10% | +3.1% |
| Q2 2014 | $4,957,000 | +14.7% | 62,967 | +9.3% | 0.10% | +3.2% |
| Q1 2014 | $4,320,000 | -6.2% | 57,607 | -3.5% | 0.09% | -10.6% |
| Q4 2013 | $4,607,000 | +5.4% | 59,676 | -5.3% | 0.10% | -1.0% |
| Q3 2013 | $4,369,000 | +6.2% | 63,023 | -3.0% | 0.10% | +10.5% |
| Q2 2013 | $4,114,000 | – | 64,985 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |